About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Careers
Case Studies
Funding Calls
Other Technologies
Pages
People
Posts
Projects
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Policy and public affairs
Technology transfer
Our science
Ventures
LifeArc, MRC and BBSRC create £18m network of gene therapy hubs to advance promising research into new treatments for patients
Post
18 March 2021
Read more
: LifeArc, MRC and BBSRC create £18m network of gene therapy hubs to advance promising research into new treatments for patients
LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
Post
8 February 2021
Read more
: LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Post
7 June 2017
Read more
: MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Partnership with TetraGenetics targets Type 1 diabetes
Post
12 December 2017
Read more
: Partnership with TetraGenetics targets Type 1 diabetes
LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus
Post
29 May 2020
Read more
: LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
Post
6 January 2021
Read more
: LifeArc funds COVID-19 drug screening hub at the University of Glasgow
UK Drug Discovery Consortium symposium
Post
23 February 2009
Read more
: UK Drug Discovery Consortium symposium
New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease
Post
21 June 2022
Read more
: New £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease
LifeArc helps create new MRC spin-out company
Post
1 September 2022
Read more
: LifeArc helps create new MRC spin-out company
LifeArc announces £10m funding call for new chronic respiratory infection therapies
Post
23 November 2022
Read more
: LifeArc announces £10m funding call for new chronic respiratory infection therapies
Repurposing therapies for EB
Funding Call
25 March 2024
Read more
: Repurposing therapies for EB
Reporting and whistleblowing information
Publication
9 April 2024
Read more
: Reporting and whistleblowing information
Previous Page
1
2
3
4
5
6
…
10
Next Page
Close Modal
WordPress development by
Andy White
using
PorterWP